Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Invyncible vs MadeMed

Invyncible
Graded #303

Lower grade

vs+19.400000000000006
MadeMed
Graded #30

Higher grade

The verdict

MadeMed takes it — 80.4/100 to 61/100.

MadeMed grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Publishes its price at every single dose, so what a titrated dose costs is knowable on day one.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMadeMed +19
55
74
Dose & formulationMadeMed +26
64
90
Clinical oversightMadeMed +14
70
84
Labs & monitoringMadeMed +10
52
62
FulfillmentMadeMed +25
65
90
Contract termsMadeMed +27
61
88
Invyncible · left barMadeMed · right bar

The numbers

MetricInvyncibleMadeMed
WeighScore61/10080.4/100
GradeCB−
Scorecard rank#303#30
Semaglutide$192/mo (0.5 mg dose, compounded)$239/mo quarterly (from $199/mo on 6 months)
Tirzepatide$210/mo (compounded)$399/mo quarterly (from $369/mo on 6 months)
Coverage40 states40 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Invyncible

Graded #303 · C

Strengths

  • Corporate parent disclosed (Nationwide Telemedicine, LLC) — better than most competitors hiding behind trade names
  • Physical corporate address published (St. Petersburg, FL)
  • LegitScript verification seal displayed
  • No long-term commitment required
  • Offers both semaglutide and tirzepatide programs

Where it loses points

  • Pricing not disclosed on the public site — fully gated behind signup
  • Drug forms (compounded vs brand, injection vs oral) not disclosed
  • 503A vs 503B designation not specified
  • Pharmacy partner not named
  • States served not listed publicly
MadeMed

Graded #30 · B−

Strengths

  • One flat price at every dose, published dose by dose — semaglutide 0.25–2.4mg, tirzepatide 2.5–15mg
  • LegitScript verified, with board-certified physician review and US compounding pharmacies
  • Full refund minus a $39 visit fee if you are not prescribed, stated before checkout
  • Oral semaglutide and oral tirzepatide alongside the injections; free overnight shipping with supplies

Where it loses points

  • The most expensive tirzepatide here at $399/mo quarterly
  • 40 states rather than nationwide
  • No published recurring lab programme
  • Ships one vial every two months, a less flexible cadence than a monthly refill

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard